Literature DB >> 29233560

Tumour infiltrating lymphocytes in breast cancer: increasing clinical relevance.

Roberto Salgado1, Sherene Loi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29233560     DOI： 10.1016/S1470-2045(17)30905-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  13 in total

1.  The scope of viral causation of human cancers: interpreting virus density from an evolutionary perspective.

Authors:  Paul W Ewald; Holly A Swain Ewald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

2.  Upregulation of Ferroptosis-Related Fanconi Anemia Group D2 is a Poor Prognostic Factor and an Indicator of Tumor Immune Cell Infiltration in Lung Adenocarcinoma.

Authors:  Jingtao Zhang; Dongli Wang; Xiubao Chen; Lingyun Ji; Minmin Yu; Minghao Guo; Dexin Zhang; Weida Chen; Fei Xu
Journal:  Front Genet       Date:  2022-05-11       Impact factor: 4.772

3.  Expression pattern, regulation, and clinical significance of TOX in breast cancer.

Authors:  Mohit Arora; Sarita Kumari; Jay Singh; Anita Chopra; Shyam S Chauhan
Journal:  Cancer Immunol Immunother       Date:  2020-08-05       Impact factor: 6.968

4.  KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.

Authors:  Yoshihisa Tokumaru; Masanori Oshi; Eriko Katsuta; Li Yan; Vikas Satyananda; Nobuhisa Matsuhashi; Manabu Futamura; Yukihiro Akao; Kazuhiro Yoshida; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

5.  Biomarker predictors for immunotherapy benefit in breast: beyond PD-L1.

Authors:  Jamaal L James; Justin M Balko
Journal:  Curr Breast Cancer Rep       Date:  2019-11-11

Review 6.  Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review.

Authors:  B Pellegrino; A Musolino; A Llop-Guevara; V Serra; P De Silva; Z Hlavata; D Sangiolo; K Willard-Gallo; C Solinas
Journal:  Transl Oncol       Date:  2020-01-02       Impact factor: 4.243

7.  Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells.

Authors:  Clara Gómez-Aleza; Bastien Nguyen; Guillermo Yoldi; Marina Ciscar; Alexandra Barranco; Enrique Hernández-Jiménez; Marion Maetens; Roberto Salgado; Maria Zafeiroglou; Pasquale Pellegrini; David Venet; Soizic Garaud; Eva M Trinidad; Sandra Benítez; Peter Vuylsteke; Laura Polastro; Hans Wildiers; Philippe Simon; Geoffrey Lindeman; Denis Larsimont; Gert Van den Eynden; Chloé Velghe; Françoise Rothé; Karen Willard-Gallo; Stefan Michiels; Purificación Muñoz; Thierry Walzer; Lourdes Planelles; Josef Penninger; Hatem A Azim; Sherene Loi; Martine Piccart; Christos Sotiriou; Eva González-Suárez
Journal:  Nat Commun       Date:  2020-12-10       Impact factor: 14.919

8.  Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review.

Authors:  Junzo Yamaguchi; Hiroki Moriuchi; Takashi Ueda; Yujo Kawashita; Takanori Hazeyama; Masaki Tateishi; Shigehisa Aoki; Kazuyoshi Uchihashi; Mikio Nakamura
Journal:  BMC Cancer       Date:  2021-04-20       Impact factor: 4.430

9.  Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumours.

Authors:  Motohiro Nonaka; Misa Suzuki-Anekoji; Jun Nakayama; Hideaki Mabashi-Asazuma; Donald L Jarvis; Jiunn-Chern Yeh; Kazuhiko Yamasaki; Tomoya O Akama; Chun-Teng Huang; Alexandre Rosa Campos; Masato Nagaoka; Toshio Sasai; Itsuko Kimura-Takagi; Yoichi Suwa; Takashi Yaegashi; Toshiaki K Shibata; Kazuhiro Sugihara; Chizuko Nishizawa-Harada; Minoru Fukuda; Michiko N Fukuda
Journal:  Br J Cancer       Date:  2020-09-14       Impact factor: 7.640

10.  Clinical implications of prospective genomic profiling of metastatic breast cancer patients.

Authors:  Courtney T van Geelen; Peter Savas; Zhi Ling Teo; Stephen J Luen; Chen-Fang Weng; Yi-An Ko; Keilly S Kuykhoven; Franco Caramia; Roberto Salgado; Prudence A Francis; Sarah-Jane Dawson; Stephen B Fox; Andrew Fellowes; Sherene Loi
Journal:  Breast Cancer Res       Date:  2020-08-18       Impact factor: 8.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.